Low risk prostate cancer in men under age 65: The case for definitive treatment
- 31 December 2007
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 25 (6) , 510-514
- https://doi.org/10.1016/j.urolonc.2007.05.025
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Expectant treatment with curative intent in the prostate-specific antigen era: Triggers for definitive therapyUrologic Oncology: Seminars and Original Investigations, 2006
- Active surveillance with selective delayed intervention for favorable risk prostate cancerUrologic Oncology: Seminars and Original Investigations, 2006
- PROGNOSTIC FEATURES IN MEN WHO DIED OF PROSTATE CANCERJournal of Urology, 2005
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- Predictors of Treatment After Initial Surveillance in Men With Prostate Cancer: Results From CaPSUREJournal of Urology, 2003
- Can Prostate Specific Antigen Derivatives and Pathological Parameters Predict Significant Change in Expectant Management Criteria for Prostate Cancer?Journal of Urology, 2003
- Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen EraJournal of Clinical Oncology, 2003
- ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- ANATOMIC RADICAL PROSTATECTOMYJournal of Urology, 1998
- ANATOMIC RADICAL PROSTATECTOMYJournal of Urology, 1998